Secondary Logo

Journal Logo

November 2016 - Volume 41 - Issue 11
pp: 837-915,e465-e492

Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients

Mayerhoefer, Marius E.; Karanikas, Georgios; Kletter, Kurt; More

Clinical Nuclear Medicine. 41(11):837-843, November 2016.





Show:
/html> <